Share on StockTwits

Titan Pharmaceuticals (NASDAQ:TTNP) issued its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01, StockRatingsNetwork reports.

Shares of Titan Pharmaceuticals (NASDAQ:TTNP) opened at 0.68 on Wednesday. Titan Pharmaceuticals has a 1-year low of $0.53 and a 1-year high of $1.27. The stock’s 50-day moving average is $0.76 and its 200-day moving average is $0.69. The company has a market cap of $60.6 million and a price-to-earnings ratio of 680.00.

On a related note, analysts at Highline Research Advisors initiated coverage on shares of Titan Pharmaceuticals in a research note on Monday, July 7th. They set a “buy” rating and a $3.00 price target on the stock.

Titan Pharmaceuticals, Inc is a biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system (NASDAQ:TTNP) disorders.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.